Human Immunodeficiency Virus and Hepatitis C Virus Infections among Patients Attending Sexually Transmitted Disease Clinics,Regional 2,Thai land

Abstract

A cross-sectional study of 400 patients attending sexually transmitted disease (STD) clinics at The Venereal Diseases and AIDS Centers, Regional 2, Thailand, was conducted from January to December 1996 in order to investigate the antibody prevalence to human immunodeficiency virus (HIV) and hepatitis C virus (HCV) and to describe some epidemiological characteristics among HIV and HCV co-infected individuals. The studied patients were interviewed and their blood specimens were collected for determining anti-HIV and anti-HCV antibodies. The results revealed that the prevalence of anti-HIV among studied patients was 25%, while 7.5% were positive for anti-HCV The positivity of both antibodies present in the same individuals was 3.3% (13/400 cases). The highest prevalences of anti-HIV, anti-HCV and both antibodies were found in studied patients aged 20 years or less. Patients with primary education, or lower, had relatively higher prevalence of anti-HIV and/ or anti-HCV than those with higher level education. A relatively higher prevalence was found among commercial sex workers and labourers. Among 13 HIV and HCV co-infected individuals, there were four cases who had histories of sexual contact without condom use, but no history of parenteral contact. The rest (9/13) had histories of both parenteral contact and sexual contact without condom use. Asia Pac J Public Health 2000;12(1):41-45

Keywords

HIV infection HCV infection patients attending STD clinics.

Get full access to this article

View all access options for this article.

References

Botherum-Boris MJ HIV prevention challenges realistic strategies and early detection programs. Am J Public Health 1997;87:544-6.

Luksamijarulkul P. , Plucktaweesak S. High hepatitis C sero-prevalence in some Thai intra-venous drug abusers and qualitative risk analysis. Southeast Asian J Trop Med Public Health 1996;27:654-8.

Luksamijarulkul P. , Tanprasert S.

Screening of hepatitis C virus antibody in HIV-risk group: Comparison between HIV-infected subjects and HIV-uninfected subjects. Chula

Med J 1999;43:307-15.

Hershow RC , Kalish LA , Sha B. , Till M. , Cohen M. Hepatitis C virus infection in Chicago women with or at risk for HIV infection: Evidence for sexual transmission. Sex Transm Dis 1998;25:527-32.

Dolan MJ , Clerici M. , Blatt SP , et al. In vitro T cell function, delayed-type hypersensitivity skin testing, and CD+4 T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J Infect Dis 1995;172:79-87.

MacNell JM , Anderson S. Beyond the dichotomy: Linking HIV prevention with care. AIDS 1998;12 (Suppl 2):S19-S26.

Cohen J. The scientific challenge of hepatitis C. Science 1999;285:26-30.

Hadziyannis SJ , Glannoulis G. , Hadziyannis E. et al. Hepatitis C virus infection in Greece and Its role in chronic liver disease and hepatocellular carcinoma. J Hepatol 1993;1 ( Suppl 3):572-7.

Tanikawa K. Relationship between hepatitis C and alcoholic liver disease. Asian Med J 1994 ; 37: 165-70.

10.

Stary A. , Kopp W. , Hofmann H. , Heller-Vitouch C. , Kunz C. Sero-epidemiologic study of hepatitis C virus in sexually transmitted disease risk groups. STDs 1992;19:252-8.

11.

Luksamijarulkul P. , Plucktaweesak S.

Anti-HIV prevalence and the comparison of some known risk behaviors between male IDUs with and without anti-HIV, seeking for methadone treatment at 2 governmental hospitals. Chula

Med J 1996;40:989-97.

12.

Kitayaporn D. , Vanichseni S. , Mastro TD et al. HIV- 1 incidence, subtypes, and follow up in a prospective cohort of injecting drug users in Bangkok, Thailand. Thai AIDS J 1998;10:219.

13.

Louisirirotchanakul S. , Thongput A. , Wasi C. , Thongcharoen P. Comparison of six anti-HCV second generation assays. Asian Pac J Allergy Immunol 1992;10(Suppl):POM-105.

14.

Natpratan P. , Apichaartplyakul C. , Bordwansin S. , Natpratan C. , Fain J. Prevalence of HIV and HCV antibodies among commercial sex workers in Chiangmai, Thailand in 1996. The 7th Scientific Annual Meeting, The Virological Association Thailand.15 Dec 1997, Bangkok , Thailand 1997; C(P) 126:160.

15.

Luksamijarulkul P. , Chompoonuch C. , Isaranurug S.

Antibody to human immunodeficiency virus P24 antigen and risk behaviors among some groups of female sex workers. Chula

Med J 1998;42:599-607.

16.

Luksamijarulkul P. , Daengbubpha A. Hepatitis C antibody prevalence and risk factors of some female sex workers in Thailand. Southeast Asian J Trop Med Public Health 1997;28:507-12.

17.

Ungchusak K. , Tongthong A. , Sangwonloy O. The 13th round of HIV sentinel serosurveillanc In Thailand, June 1995 . Thai AIDS J 1995;7:177-89.

18.

Boonmar S. Sawanpanyalert P. , Miyamura T. Risk factors for hepatitis C virus infection among blood donors in an HIV-epidemic area in Thailand. The 13th National Seminar on Epidemiology , Bangkok, Thailand 1995;146-7.

19.

Chen DS , Kuo CC , Sung JL et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease. The Taiwan experience. J Infect Dis 1990;162:817-22.

20.

Luksamijarulkul P. , Daengbubpha A. Insufficient condom use among some groups of female sex workers: quan